The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
The role of exosomes and miRNAs in drug‐resistance of cancer cells
Open accessAbstract
Chemotherapy, one of the principal approaches for cancer patients, plays a crucial role in controlling tumor progression. Clinically, tumors reveal a satisfactory response following the first exposure to the chemotherapeutic drugs in treatment. However, most tumors sooner or later become resistant to even chemically unrelated anticancer agents after repeated treatment. The reduced drug accumulation in tumor cells is considered one of the significant mechanisms by decreasing drug permeability and/or increasing active efflux (pumping out) of the drugs across the cell membrane. The mechanisms of treatment failure of chemotherapeutic drugs have been investigated, including drug efflux, which is mediated by extracellular vesicles (EVs). Exosomes, a subset of EVs with a size range of 40–150 nm and a lipid bilayer membrane, can be released by all cell types. They mediate specific cell‐to‐cell interactions and activate signaling pathways in cells they either fuse with or interact with, including cancer cells. Exosomal RNAs are heterogeneous in size but enriched in small RNAs, such as miRNAs. In the primary tumor microenvironment, cancer‐secreted exosomes and miRNAs can be internalized by other cell types. MiRNAs loaded in these exosomes might be transferred to recipient niche cells to exert genome‐wide regulation of gene expression. How exosomal miRNAs contribute to the development of drug resistance in the context of the tumor microenvironment has not been fully described. In this review, we will highlight recent studies regarding EV‐mediated microRNA delivery in formatting drug resistance. We also suggest the use of EVs as an advancing method in antiresistance treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedSharifi, M., Salehi, R., Gheisari, Y., & Kazemi, M. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3134-5 · Cited by 45
RetractedValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Identification of Novel Genes Coding for Small Expressed RNAs
Lagos-Quintana, M., Rauhut, R., Lendeckel, W., & Tuschl, T. (2001) · Science · doi:10.1126/science.1064921 · Cited by 4,956
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
Exosomes – vesicular carriers for intercellular communication
Simons, M., & Raposo, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.03.007 · Cited by 2,351
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., & Rak, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1725 · Cited by 2,034
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., & Ochiya, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107821 · Cited by 1,934
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells
Mittelbrunn, M., Gutiérrez-Vázquez, C., Villarroya-Beltri, C., González, S., Sánchez-Cabo, F., González, M. Á., Bernad, A., & Sánchez-Madrid, F. (2011) · Nature Communications · doi:10.1038/ncomms1285 · Cited by 1,769
Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07077.x · Cited by 1,735
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Melo, S. A., Sugimoto, H., O’Connell, J. T., Kato, N., Villanueva, A., Vidal, A., Qiu, L., Vitkin, E., Perelman, L. T., Melo, C. A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.005 · Cited by 1,531
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476 · cited 2×
“Exosomal miR105 released from the breast cancer cell lines MCF-10 A and MDA-MB-231 reduced the level of ZO-1 gene expression in endothelial cells and promoted metastases to the lung and brain.(98) Exosomal miR-214, derived from the human microvascular endothelial cell line HMEC-1, promoted migration and angiogenesis i…”
BackgroundExoCarta: A Web-Based Compendium of Exosomal Cargo
Keerthikumar, S., Chisanga, D., Ariyaratne, D., Al Saffar, H., Anand, S., Zhao, K., Samuel, M., Pathan, M., Jois, M., Chilamkurti, N., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.09.019 · Cited by 1,452
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209414109 · Cited by 1,434
Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation
Kalra, H., Simpson, R. J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V. C., Borràs, F. E., Breakefield, X., Budnik, V., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001450 · Cited by 1,367
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Rabinowits, G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., & Kloecker, G. H. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.006 · Cited by 1,262
MicroRNA Pathways in Flies and Worms
Ambros, V. (2003) · Cell · doi:10.1016/s0092-8674(03)00428-8 · Cited by 1,217
Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration
Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., Sun, F., Lu, J., Yin, Y., Cai, X., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.010 · Cited by 1,195
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Ng, E. K. O., Chong, W. W. S., Jin, H., Lam, E. K. Y., Shin, V. Y., Yu, J., Poon, T. C. W., Ng, S. S. M., & Sung, J. J. Y. (2009) · Gut · doi:10.1136/gut.2008.167817 · Cited by 1,151
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
Qu, L., Ding, J., Chen, C., Wu, Z.-J., Liu, B., Gao, Y., Chen, W., Liu, F., Sun, W., Li, X.-F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.004 · Cited by 1,117
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Kim, S., Takahashi, H., Lin, W.-W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.-L., & Karin, M. (2009) · Nature · doi:10.1038/nature07623 · Cited by 1,100
ExoCarta 2012: database of exosomal proteins, RNA and lipids
Mathivanan, S., Fahner, C. J., Reid, G. E., & Simpson, R. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr828 · Cited by 1,094
Exosomes Released by Melanoma Cells Prepare Sentinel Lymph Nodes for Tumor Metastasis
Hood, J. L., San, R. S., & Wickline, S. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4455 · Cited by 1,036
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
ExoCarta: A compendium of exosomal proteins and RNA
Mathivanan, S., & Simpson, R. J. (2009) · PROTEOMICS · doi:10.1002/pmic.200900351 · Cited by 873
In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior
Zomer, A., Maynard, C., Verweij, F. J., Kamermans, A., Schäfer, R., Beerling, E., Schiffelers, R. M., de Wit, E., Berenguer, J., Ellenbroek, S. I. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.042 · Cited by 869
Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation
Webber, J., Steadman, R., Mason, M. D., Tabi, Z., & Clayton, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1722 · Cited by 852
Grange, C., Tapparo, M., Collino, F., Vitillo, L., Damasco, C., Deregibus, M. C., Tetta, C., Bussolati, B., & Camussi, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0241 · Cited by 851
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Boelens, M. C., Wu, T. J., Nabet, B. Y., Xu, B., Qiu, Y., Yoon, T., Azzam, D. J., Twyman-Saint Victor, C., Wiemann, B. Z., Ishwaran, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.051 · Cited by 806
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Miller, T. E., Ghoshal, K., Ramaswamy, B., Roy, S., Datta, J., Shapiro, C. L., Jacob, S., & Majumder, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804612200 · Cited by 749
Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., et al. (1995) · Blood · doi:10.1182/blood.v85.6.1580.bloodjournal8561580 · Cited by 732
Changes in circulating microRNA levels associated with prostate cancer
Bryant, R. J., Pawlowski, T., Catto, J. W. F., Marsden, G., Vessella, R. L., Rhees, B., Kuslich, C., Visakorpi, T., & Hamdy, F. C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.595 · Cited by 715
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23501 · Cited by 711
Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., Liu, Y., Huang, J.-D., & Song, E. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-117 · Cited by 693
Resnick, K. E., Alder, H., Hagan, J. P., Richardson, D. L., Croce, C. M., & Cohn, D. E. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.036 · Cited by 647
Liu, Y., Gu, Y., Han, Y., Zhang, Q., Jiang, Z., Zhang, X., Huang, B., Xu, X., Zheng, J., & Cao, X. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.021 · Cited by 640
Kovalchuk, O., Filkowski, J., Meservy, J., Ilnytskyy, Y., Tryndyak, V. P., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 635
Circulating microRNAs in plasma of patients with gastric cancers
Tsujiura, M., Ichikawa, D., Komatsu, S., Shiozaki, A., Takeshita, H., Kosuga, T., Konishi, H., Morimura, R., Deguchi, K., Fujiwara, H., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605608 · Cited by 628
Safaei, R., Larson, B. J., Cheng, T. C., Gibson, M. A., Otani, S., Naerdemann, W., & Howell, S. B. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0102 · Cited by 564
van Balkom, B. W. M., de Jong, O. G., Smits, M., Brummelman, J., den Ouden, K., de Bree, P. M., van Eijndhoven, M. A. J., Pegtel, D. M., Stoorvogel, W., Würdinger, T., et al. (2013) · Blood · doi:10.1182/blood-2013-02-478925 · Cited by 515
Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy
Ciravolo, V., Huber, V., Ghedini, G. C., Venturelli, E., Bianchi, F., Campiglio, M., Morelli, D., Villa, A., Mina, P. D., Menard, S., et al. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22773 · Cited by 514
Cancer as a robust system: implications for anticancer therapy
Kitano, H. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1300 · Cited by 456
Zhu, H., Wu, H., Liu, X., Evans, B. R., Medina, D. J., Liu, C.-G., & Yang, J.-M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.007 · Cited by 456
Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?
Callaghan, R., Luk, F., & Bebawy, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056176 · Cited by 453
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Asaga, S., Kuo, C., Nguyen, T., Terpenning, M., Giuliano, A. E., & Hoon, D. S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.151845 · Cited by 451
Corcoran, C., Rani, S., O’Brien, K., O’Neill, A., Prencipe, M., Sheikh, R., Webb, G., McDermott, R., Watson, W., Crown, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050999 · Cited by 448
Tanaka, Y., Kamohara, H., Kinoshita, K., Kurashige, J., Ishimoto, T., Iwatsuki, M., Watanabe, M., & Baba, H. (2013) · Cancer · doi:10.1002/cncr.27895 · Cited by 446
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma
Sohn, W., Kim, J., Kang, S. H., Yang, S. R., Cho, J.-Y., Cho, H. C., Shim, S. G., & Paik, Y.-H. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.68 · Cited by 426
Di Vizio, D., Kim, J., Hager, M. H., Morello, M., Yang, W., Lafargue, C. J., True, L. D., Rubin, M. A., Adam, R. M., Beroukhim, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3860 · Cited by 423
Chen, W.-X., Liu, X.-M., Lv, M.-M., Chen, L., Zhao, J.-H., Zhong, S.-L., Ji, M.-H., Hu, Q., Luo, Z., Wu, J.-Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095240 · Cited by 420
Exosomal miRNAs: Biological Properties and Therapeutic Potential
Hu, G., Drescher, K. M., & Chen, X.-M. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00056 · Cited by 394
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
Ji, Q., Hao, X., Meng, Y., Zhang, M., DeSano, J., Fan, D., & Xu, L. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-266 · Cited by 394
The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation.
Ueda, K., Clark, D. P., Chen, C. J., Roninson, I. B., Gottesman, M. M., & Pastan, I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75806-2 · Cited by 388
Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
Fontana, L., Fiori, M. E., Albini, S., Cifaldi, L., Giovinazzi, S., Forloni, M., Boldrini, R., Donfrancesco, A., Federici, V., Giacomini, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002236 · Cited by 385
Shedden, K., Xie, X. T., Chandaroy, P., Chang, Y., & Rosania, G. R. (2003) · PubMed · Cited by 385
ExoCarta as a resource for exosomal research
Simpson, R. J., Kalra, H., & Mathivanan, S. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18374 · Cited by 383
Aung, T., Chapuy, B., Vogel, D., Wenzel, D., Oppermann, M., Lahmann, M., Weinhage, T., Menck, K., Hupfeld, T., Koch, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102855108 · Cited by 374
Lee, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1193 · Cited by 365
MicroRNAs modulate the chemosensitivity of tumor cells
Blower, P. E., Chung, J.-H., Verducci, J. S., Lin, S., Park, J.-K., Dai, Z., Liu, C.-G., Schmittgen, T. D., Reinhold, W. C., Croce, C. M., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0573 · Cited by 364
Challagundla, K. B., Wise, P. M., Neviani, P., Chava, H., Murtadha, M., Xu, T., Kennedy, R., Ivan, C., Zhang, X., Vannini, I., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv135 · Cited by 359
Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
Wei, Y., Lai, X., Yu, S., Chen, S., Ma, Y., Zhang, Y., Li, H., Zhu, X., Yao, L., & Zhang, J. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3037-0 · Cited by 354
Role of microRNAs in drug-resistant ovarian cancer cells
Sorrentino, A., Liu, C.-G., Addario, A., Peschle, C., Scambia, G., & Ferlini, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.017 · Cited by 354
Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin
Federici, C., Petrucci, F., Caimi, S., Cesolini, A., Logozzi, M., Borghi, M., D'Ilio, S., Lugini, L., Violante, N., Azzarito, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088193 · Cited by 354
Yang, N., Kaur, S., Volinia, S., Greshock, J., Lassus, H., Hasegawa, K., Liang, S., Leminen, A., Deng, S., Smith, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1954 · Cited by 352
Ying, X., Wu, Q., Wu, X., Zhu, Q., Wang, X., Jiang, L., Chen, X., & Wang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9246 · Cited by 348
CD44v6 Dependence of Premetastatic Niche Preparation by Exosomes
Jung, T., Castellana, D., Klingbeil, P., Hernández, I. C., Vitacolonna, M., Orlicky, D. J., Roffler, S. R., Brodt, P., & Zöller, M. (2009) · Neoplasia · doi:10.1593/neo.09822 · Cited by 345
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Fujita, Y., Kojima, K., Hamada, N., Ohhashi, R., Akao, Y., Nozawa, Y., Deguchi, T., & Ito, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.086 · Cited by 331
Zhang, H., Yang, L., Zhu, Y., Yao, X., Zhang, S., Dai, B., Zhu, Y., Shen, Y., Shi, G., & Ye, D. (2011) · The Prostate · doi:10.1002/pros.21246 · Cited by 322
Pan, Y.-Z., Morris, M. E., & Yu, A.-M. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054163 · Cited by 309
miR‐181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Zhu, W., Shan, X., Wang, T., Shu, Y., & Liu, P. (2010) · International Journal of Cancer · doi:10.1002/ijc.25260 · Cited by 299
Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients
Tanaka, M., Oikawa, K., Takanashi, M., Kudo, M., Ohyashiki, J., Ohyashiki, K., & Kuroda, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005532 · Cited by 298
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
Garofalo, M., Quintavalle, C., Di Leva, G., Zanca, C., Romano, G., Taccioli, C., Liu, C. G., Croce, C. M., & Condorelli, G. (2008) · Oncogene · doi:10.1038/onc.2008.6 · Cited by 289
miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer
Foss, K. M., Sima, C., Ugolini, D., Neri, M., Allen, K. E., & Weiss, G. J. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318208c785 · Cited by 281
O’Brien, K., Lowry, M. C., Corcoran, C., Martinez, V. G., Daly, M., Rani, S., Gallagher, W. M., Radomski, M. W., MacLeod, R. A. F., & O’Driscoll, L. (2015) · Oncotarget · doi:10.18632/oncotarget.5192 · Cited by 273
Competitive Interactions of Cancer Cells and Normal Cells via Secretory MicroRNAs
Kosaka, N., Iguchi, H., Yoshioka, Y., Hagiwara, K., Takeshita, F., & Ochiya, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.288662 · Cited by 267
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
Ng, E. K. O., Li, R., Shin, V. Y., Jin, H. C., Leung, C. P. H., Ma, E. S. K., Pang, R., Chua, D., Chu, K.-M., Law, W. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053141 · Cited by 263
Exosome-Like Vesicles with Dipeptidyl Peptidase IV in Human Saliva
Ogawa, Y., Kanai-Azuma, M., Akimoto, Y., Kawakami, H., & Yanoshita, R. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1059 · Cited by 258
Nakajima, G., Hayashi, K., Xi, Y., Kudo, K., Uchida, K., Takasaki, K., Yamamoto, M., & Ju, J. (2006) · PubMed · Cited by 253
Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3
Tsang, W. P., & Kwok, T. T. (2008) · Apoptosis · doi:10.1007/s10495-008-0256-z · Cited by 247
Purification, characterization and biological significance of tumor-derived exosomes.
Koga, K., Matsumoto, K., Akiyoshi, T., Kubo, M., Yamanaka, N., Tasaki, A., Nakashima, H., Nakamura, M., Kuroki, S., Tanaka, M., et al. (2005) · PubMed · Cited by 240
O’Brien, K., Rani, S., Corcoran, C., Wallace, R., Hughes, L., Friel, A. M., McDonnell, S., Crown, J., Radomski, M. W., & O’Driscoll, L. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.01.017 · Cited by 239
Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer
Sun, Y., Wang, M., Lin, G., Sun, S., Li, X., Qi, J., & Li, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047003 · Cited by 239
Corcoran, C., Rani, S., & O'Driscoll, L. (2014) · The Prostate · doi:10.1002/pros.22848 · Cited by 223
MicroRNAs are exported from malignant cells in customized particles
Palma, J., Yaddanapudi, S. C., Pigati, L., Havens, M. A., Jeong, S., Weiner, G. A., Weimer, K. M. E., Stern, B., Hastings, M. L., & Duelli, D. M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks656 · Cited by 221
Pink, R. C., Samuel, P., Massa, D., Caley, D. P., Brooks, S. A., & Carter, D. R. F. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.042 · Cited by 218
Taniai, M., Grambihler, A., Higuchi, H., Werneburg, N., Bronk, S. F., Farrugia, D. J., Kaufmann, S. H., & Gores, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2770 · Cited by 218
MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma
Yamamoto, Y., Kosaka, N., Tanaka, M., Koizumi, F., Kanai, Y., Mizutani, T., Murakami, Y., Kuroda, M., Miyajima, A., Kato, T., et al. (2009) · Biomarkers · doi:10.3109/13547500903150771 · Cited by 216
He, C., Dong, X., Zhai, B., Jiang, X., Dong, D., Li, B., Jiang, H., Xu, S., & Sun, X. (2015) · Oncotarget · doi:10.18632/oncotarget.4814 · Cited by 214
miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
Yang, S.-M., Huang, C., Li, X.-F., Yu, M.-Z., He, Y., & Li, J. (2013) · Toxicology · doi:10.1016/j.tox.2013.02.014 · Cited by 211
Emission of membrane vesicles: roles in complement resistance, immunity and cancer
Pilzer, D., Gasser, O., Moskovich, O., Schifferli, J. A., & Fishelson, Z. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-005-0004-1 · Cited by 199
Li, B., Ren, S., Li, X., Wang, Y., Garfield, D., Zhou, S., Chen, X., Su, C., Chen, M., Kuang, P., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.003 · Cited by 177
MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN
Wang, F., Li, T., Zhang, B., Li, H., Wu, Q., Yang, L., Nie, Y., Wu, K., Shi, Y., & Fan, D. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.010 · Cited by 170
miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
Sun, C., Li, N., Yang, Z., Zhou, B., He, Y., Weng, D., Fang, Y., Wu, P., Chen, P., Yang, X., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt302 · Cited by 169
Fornari, F., Pollutri, D., Patrizi, C., La Bella, T., Marinelli, S., Casadei Gardini, A., Marisi, G., Baron Toaldo, M., Baglioni, M., Salvatore, V., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1464 · Cited by 168
Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles
Sousa, D., Lima, R. T., & Vasconcelos, M. H. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.08.002 · Cited by 162
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC
Battke, C., Ruiss, R., WELSCH, U. N., Wimberger, P., Lang, S., Jochum, S., & Zeidler, R. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0979-5 · Cited by 155
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5
Sun, H., Cui, R., Zhou, J., Teng, K., Hsiao, Y., Nakanishi, K., Fassan, M., Luo, Z., Shi, G., Tili, E., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.001 · Cited by 147
Cancer robustness: Tumour tactics
Kitano, H. (2003) · Nature · doi:10.1038/426125a · Cited by 146
Chaput, N., Ta�eb, J., Schartz, N., André, F., Angevin, E., & Zitvogel, L. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0472-x · Cited by 141
Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
Kanlikilicer, P., Rashed, M. H., Bayraktar, R., Mitra, R., Ivan, C., Aslan, B., Zhang, X., Filant, J., da Silva, A. M., Rodriguez‐Aguayo, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0714 · Cited by 136
Ma, Y., Tian, Z., & Zhang, W. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1285-0 · Cited by 135
Yin, J., Yan, X., Yao, X., Zhang, Y., Shan, Y., Mao, N., Yang, Y., & Pan, L. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01316.x · Cited by 133
Rosell, R., Wei, J., & Tarón, M. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.001 · Cited by 133
Xin, F., Li, M., Balch, C., Thomson, M., Fan, M., Liu, Y., Hammond, S. M., Kim, S., & Nephew, K. P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn646 · Cited by 123
Circulating microRNAs predict biochemical recurrence in prostate cancer patients
BioResource, O. B. O. T. A. P. C., Selth, L. A., Townley, S. L., Bert, A. G., Stricker, P. D., Sutherland, P. D., Horvath, L. G., Goodall, G. J., Butler, L. M., & Tilley, W. D. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.369 · Cited by 120
Franchina, T., Amodeo, V., Bronte, G., Savio, G., Ricciardi, G. R. R., Picciotto, M., Russo, A. D., Giordano, A., & Adamo, V. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24422 · Cited by 118
Cui, E., Li, H., Hua, F., Wang, B., Mao, W., Feng, X., Li, J.-Y., & Wang, X. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.125 · Cited by 96
A primate virus generates transformed human cells by fusion
Duelli, D. M., Hearn, S., Myers, M. P., & Lazebnik, Y. A. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507069 · Cited by 96
Chen, G., Zhao, Z., Zhou, H., Liu, Y., & Yang, H. (2009) · Medical Oncology · doi:10.1007/s12032-009-9225-9 · Cited by 90
Rasmussen, M. H., Jensen, N. F., Tarpgaard, L. S., Qvortrup, C., Rømer, M. U., Stenvang, J., Hansen, T. P., Christensen, L. L., Lindebjerg, J., Hansen, F., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.016 · Cited by 85
Pan, C., Wang, X., Shi, K., Zheng, Y., Li, J., Chen, Y., Jin, L., & Pan, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152090 · Cited by 83
Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs
Sorrentino, B. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc823 · Cited by 82
Climent, J., Dimitrow, P., Fridlyand, J., Palacios, J., Siebert, R., Albertson, D. G., Gray, J. W., Pinkel, D., Lluch, A. M., & Martinez-Climent, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3307 · Cited by 82
miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells
Fang, Y., Shen, H., Li, H., Cao, Y., Qin, R., Long, L., Zhu, X., Xie, C., & Xu, W. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt106 · Cited by 77
Bae, S. Y., Hong, J., Lee, H., Park, H. J., & Lee, S. K. (2015) · Oncotarget · doi:10.18632/oncotarget.3380 · Cited by 76
Self-citationTaylor, D. D., Homesley, H. D., & Doellgast, G. J. (1980) · PubMed · Cited by 76
Shed Membrane Fragment-Associated Markers for Endometrial and Ovarian Cancers
Taylor, D. D., Lyons, K. S., & Gerçel-Taylor, Ç. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6551 · Cited by 74
Bullerdiek, J., & Flor, I. (2012) · Molecular Cytogenetics · doi:10.1186/1755-8166-5-27 · Cited by 72
Review: Cancer Immunotherapy by Exosome-Based Vaccines
Hao, S., Moyana, T. N., & Xiang, J. (2007) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.368-r · Cited by 64
Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography
Taylor, D. D., & Doellgast, G. J. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90704-8 · Cited by 63
MicroRNAs delivered by extracellular vesicles: an emerging resistance mechanism for breast cancer
Chen, W., Zhong, S., Ji, M., Pan, M., Hu, Q., Lv, M., Zhou, L., Zhao, J., & Tang, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-1417-4 · Cited by 56
Exosomes as novel therapeutic nanodevices.
Delcayre, A. X., & Pecq, J. L. (2006) · PubMed · Cited by 52
Lee, S.-C., Min, H., Choi, H., Bae, S. Y., Park, K. H., Hyun, S. Y., Lee, H. J., Moon, J., Park, S., Kim, J. Y., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1492 · Cited by 49
Self-citationAldonza, M. B. D., Hong, J., Alinsug, M. V., Song, J., & Lee, S. K. (2016) · Oncotarget · doi:10.18632/oncotarget.9118 · Cited by 44
Self-citationAntagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel
Jin, B. R., Liu, Y., & Wang, H. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0450-2 · Cited by 39
Aldonza, M. B. D., Hong, J., Bae, S. Y., Song, J., Kim, W. K., Oh, J., Shin, Y., Lee, S. H., & Lee, S. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127841 · Cited by 31
Self-citationPilzer, D., Gasser, O., Moskovich, O., Schifferli, J. A., & Fishelson, Z. (2005) · Cited by 26
Bae, S. Y., Park, H. J., Hong, J., Lee, H., & Lee, S. K. (2016) · Scientific Reports · doi:10.1038/srep32258 · Cited by 23
Self-citation
Cited by
Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
Mashouri, L., Yousefi, H., Aref, A. R., Ahadi, A. M., Molaei, F., & Alahari, S. K. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0991-5 · Cited by 1,363
Zhao, S., Mi, Y., Guan, B., Zheng, B., Wei, P., Gu, Y., Zhang, Z., Cai, S., Xu, Y., Li, X., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00991-2 · Cited by 778
Exosomal circRNAs: biogenesis, effect and application in human diseases
Wang, Y., Liu, J., Ma, J., Sun, T., Zhou, Q., Wang, W., Wang, G., Wu, P., Wang, H., Jiang, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1041-z · Cited by 636
The biology, function, and applications of exosomes in cancer
Liu, J., Ren, L., Li, S., Li, W., Zheng, X., Yang, Y., Fu, W., Yi, J., Wang, J., & Du, G. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.001 · Cited by 561
Qin, X., Guo, H., Wang, X., Zhu, X., Yan, M., Wang, X., Xu, Q., Shi, J., Lu, E., Chen, W., et al. (2019) · Genome Biology · doi:10.1186/s13059-018-1604-0 · Cited by 431
Metadata
- Authors
- Bach, D., Hong, J., Park, H. J., & Lee, S. K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2017-03-11
- Volume
- 141
- Issue
- 2
- Pages
- 220-230
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2593878027
- Cited by
- 296
- References
- 137
- FWCI
- 14.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.